A citation-based method for searching scientific literature

Chethan Ramamurthy, Yana Chertock, Michael J Hall. Surg Oncol Clin N Am 2017
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Karin M Hardiman, Jianhua Liu, Ying Feng, Joel K Greenson, Eric R Fearon. PLoS One 2014
24
100

Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
D Labayle, D Fischer, P Vielh, F Drouhin, A Pariente, C Bories, O Duhamel, M Trousset, P Attali. Gastroenterology 1991
598
100

Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System.
Umed A Ajani, Earl S Ford, Kurt J Greenland, Wayne H Giles, Ali H Mokdad. Am J Prev Med 2006
136
100

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
Frank L Meyskens, Christine E McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M Carpenter, Ernest Hawk, Gary Kelloff, Michael J Lawson, Jayashri Kidao, John McCracken,[...]. Cancer Prev Res (Phila) 2008
364
100


Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
Michael G Backlund, Jason R Mann, Raymond N Dubois. Oncology 2005
84
100

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.
Gillian Libby, Louise A Donnelly, Peter T Donnan, Dario R Alessi, Andrew D Morris, Josie M M Evans. Diabetes Care 2009
741
100

Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
F L Meyskens, E W Gerner, S Emerson, D Pelot, T Durbin, K Doyle, W Lagerberg. J Natl Cancer Inst 1998
106
100


Familial adenomatous polyposis.
James Church. Surg Oncol Clin N Am 2009
16
100

Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.
H Li, H A Schut, P Conran, P M Kramer, R A Lubet, V E Steele, E E Hawk, G J Kelloff, M A Pereira. Carcinogenesis 1999
82
100

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction.
Sung Yong Ahn, Nam Hee Kim, Kyungro Lee, Yong Hoon Cha, Ji Hye Yang, So Young Cha, Eunae Sandra Cho, Yoonmi Lee, Jeong Seok Cha, Hyun Soo Cho,[...]. Oncotarget 2017
17
100

Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Tracy Murray-Stewart, Matthew Dunworth, Yuan Lui, Francis M Giardiello, Patrick M Woster, Robert A Casero. PLoS One 2018
15
100

Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Takuma Higurashi, Kunihiro Hosono, Hirokazu Takahashi, Yasuhiko Komiya, Shotaro Umezawa, Eiji Sakai, Takashi Uchiyama, Leo Taniguchi, Yasuo Hata, Shiori Uchiyama,[...]. Lancet Oncol 2016
151
100

Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
Amy E Moran, Daniel H Hunt, Sara H Javid, Mark Redston, Adelaide M Carothers, Monica M Bertagnolli. J Biol Chem 2004
86
100

Celecoxib for the prevention of colorectal adenomatous polyps.
Nadir Arber, Craig J Eagle, Julius Spicak, István Rácz, Petr Dite, Jan Hajer, Miroslav Zavoral, Maria J Lechuga, Paola Gerletti, Jie Tang,[...]. N Engl J Med 2006
725
100

Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
N Jewel Samadder, Scott K Kuwada, Kenneth M Boucher, Kathryn Byrne, Priyanka Kanth, Wade Samowitz, David Jones, Sean V Tavtigian, Michelle Westover, Therese Berry,[...]. JAMA Oncol 2018
28
100

Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis.
Nicholas J West, Susan K Clark, Robin K S Phillips, John M Hutchinson, Roger J Leicester, Andrea Belluzzi, Mark A Hull. Gut 2010
133
100

The effect of ursodesoxycholic acid on duodenal adenomas in familial adenomatous polyposis: a prospective randomized placebo-control trial.
Y Parc, B Desaint, J-F Fléjou, J H Lefèvre, L Serfaty, A Vienne, S Kotti, T Simon, E Tiret. Colorectal Dis 2012
9
100


An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
Patrick M Lynch, Carol A Burke, Robin Phillips, Jeffrey S Morris, Rebecca Slack, Xuemei Wang, Jun Liu, Sherri Patterson, Frank A Sinicrope, Miguel A Rodriguez-Bigas,[...]. Gut 2016
49
100

Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
Jessica Chubak, Evelyn P Whitlock, Selvi B Williams, Aruna Kamineni, Brittany U Burda, Diana S M Buist, Melissa L Anderson. Ann Intern Med 2016
111
100

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
R K S Phillips, M H Wallace, P M Lynch, E Hawk, G B Gordon, B P Saunders, N Wakabayashi, Y Shen, S Zimmerman, L Godio,[...]. Gut 2002
298
100

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
Peter M Rothwell, Michelle Wilson, Carl-Eric Elwin, Bo Norrving, Ale Algra, Charles P Warlow, Tom W Meade. Lancet 2010
852
100

Primary chemoprevention of familial adenomatous polyposis with sulindac.
Francis M Giardiello, Vincent W Yang, Linda M Hylind, Anne J Krush, Gloria M Petersen, Jill D Trimbath, Steven Piantadosi, Elizabeth Garrett, Deborah E Geiman, Walter Hubbard,[...]. N Engl J Med 2002
248
100

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
G Steinbach, P M Lynch, R K Phillips, M H Wallace, E Hawk, G B Gordon, N Wakabayashi, B Saunders, Y Shen, T Fujimura,[...]. N Engl J Med 2000
100

Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis.
Marcia Cruz-Correa, Linda M Hylind, Jessica Hernandez Marrero, Marianna L Zahurak, Tracy Murray-Stewart, Robert A Casero, Elizabeth A Montgomery, Christine Iacobuzio-Donahue, Lodewijk A Brosens, G Johan Offerhaus,[...]. Gastroenterology 2018
38
100


Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
N Jewel Samadder, Deborah W Neklason, Kenneth M Boucher, Kathryn R Byrne, Priyanka Kanth, Wade Samowitz, David Jones, Sean V Tavtigian, Michelle W Done, Therese Berry,[...]. JAMA 2016
68
100

Use of Colorectal Cancer Screening Tests by State.
Djenaba A Joseph, Jessica B King, Thomas B Richards, Cheryll C Thomas, Lisa C Richardson. Prev Chronic Dis 2018
32
100

Underutilization of Aspirin in Patients With Advanced Colorectal Polyps.
Benjamin Fiedler, Lawrence Fiedler, Michael DeDonno, Kosi Anago, Leonie de la Cruz, George R Luck, Charles H Hennekens. Am J Med 2019
3
100

Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
Mark A Hull, Kirsty Sprange, Trish Hepburn, Wei Tan, Aisha Shafayat, Colin J Rees, Gayle Clifford, Richard F Logan, Paul M Loadman, Elizabeth A Williams,[...]. Lancet 2018
57
100

Lynch Syndrome-Associated Colorectal Cancer.
Frank A Sinicrope. N Engl J Med 2018
72
100

Aspirin use and incidence of large-bowel cancer in a California retirement community.
A Paganini-Hill, G Hsu, R K Ross, B E Henderson. J Natl Cancer Inst 1991
74
100


Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.
Aung Ko Win, Mark A Jenkins, James G Dowty, Antonis C Antoniou, Andrew Lee, Graham G Giles, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Dennis J Ahnen,[...]. Cancer Epidemiol Biomarkers Prev 2017
150
100

Celecoxib for the prevention of sporadic colorectal adenomas.
Monica M Bertagnolli, Craig J Eagle, Ann G Zauber, Mark Redston, Scott D Solomon, KyungMann Kim, Jie Tang, Rebecca B Rosenstein, Janet Wittes, Donald Corle,[...]. N Engl J Med 2006
770
100


Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
John Burn, D Timothy Bishop, Jukka-Pekka Mecklin, Finlay Macrae, Gabriela Möslein, Sylviane Olschwang, Marie-Luise Bisgaard, Raj Ramesar, Diana Eccles, Eamonn R Maher,[...]. N Engl J Med 2008
185
100

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.
John Burn, D Timothy Bishop, Pamela D Chapman, Faye Elliott, Lucio Bertario, Malcolm G Dunlop, Diana Eccles, Anthony Ellis, D Gareth Evans, Riccardo Fodde,[...]. Cancer Prev Res (Phila) 2011
123
100

Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.
Bjorn W H van Heumen, Hennie M J Roelofs, M Elisa Vink-Börger, Evelien Dekker, Elisabeth M H Mathus-Vliegen, Jan Dees, Jan J Koornstra, Alexandra M J Langers, Iris D Nagtegaal, Ellen Kampman,[...]. Orphanet J Rare Dis 2013
10
100

Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
Marcia Cruz-Correa, Daniel A Shoskes, Patricia Sanchez, Rhongua Zhao, Linda M Hylind, Steven D Wexner, Francis M Giardiello. Clin Gastroenterol Hepatol 2006
240
100

IL-23 in inflammatory bowel diseases and colon cancer.
Markus F Neurath. Cytokine Growth Factor Rev 2019
64
100

Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
Carol A Burke, Evelien Dekker, Patrick Lynch, N Jewel Samadder, Francesc Balaguer, Robert Hüneburg, John Burn, Antoni Castells, Steven Gallinger, Ramona Lim,[...]. N Engl J Med 2020
8
100

Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
Reade B Roberts, Lu Min, M Kay Washington, Sandra J Olsen, Stephen H Settle, Robert J Coffey, David W Threadgill. Proc Natl Acad Sci U S A 2002
227
100

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
Driss Ait Ouakrim, Seyedeh Ghazaleh Dashti, Rowena Chau, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Ingrid M Winship, Joanne P Young, Graham G Giles, Barbara Leggett,[...]. J Natl Cancer Inst 2015
54
100

Statins and colorectal cancer.
Paul Lochhead, Andrew T Chan. Clin Gastroenterol Hepatol 2013
53
100

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
F M Giardiello, S R Hamilton, A J Krush, S Piantadosi, L M Hylind, P Celano, S V Booker, C R Robinson, G J Offerhaus. N Engl J Med 1993
100

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
Scott D Solomon, John J V McMurray, Marc A Pfeffer, Janet Wittes, Robert Fowler, Peter Finn, William F Anderson, Ann Zauber, Ernest Hawk, Monica Bertagnolli. N Engl J Med 2005
100

Hereditary Polyposis Syndromes.
Trilokesh D Kidambi, Divyanshoo R Kohli, N Jewel Samadder, Aparajita Singh. Curr Treat Options Gastroenterol 2019
7
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.